Dose-dependent change in biomarkers during neoadjuvant endocrine therapy with fulvestrant: results from NEWEST, a randomized Phase II study

Authors: Irene Kuter, Julia M.W. Gee, Roberto Hegg, Christian F. Singer, Rajendra Badwe, Elizabeth Lowe, Ugochi Emeribe, Elizabeth J. Anderson, Francisco Sapunar, Pauline Finlay, Robert I. Nicholson, José Bines, Nadia Harbeck - Breast Cancer Research and Treatment 2012 cited by 99